Dr. Walter Flamenbaum retired from the board of directors of MiNK Therapeutics, Inc., effective December 31, 2021. The company previously reported Dr. Flamenbaum's intent to retire on December 31, 2021 in its amended registration statement on Form S-1 filed on October 12, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.94 USD | -2.09% | -5.05% | -12.15% |
05-14 | Transcript : MiNK Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | MiNK Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.15% | 33.32M | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- INKT Stock
- News MiNK Therapeutics, Inc.
- MiNK Therapeutics, Inc. Announces Retirement of Walter Flamenbaum as Board of Director